University of Washington
Seattle, Washington, 98195, United States
NCT Number: NCT00161486
The purpose of this research study is to understand the effects of testosterone on the prostate. This knowledge will be used to help in the development of a safe male hormonal contraceptive and may impact the development of androgen replacement therapy in older men.
Looking for future studies?
Notify Me35 year–55 year
Male
Interventional
Phase 1
Seattle, Washington, 98195, United States
We will be administering two drugs: Testim (testosterone gel) and Acyline. Acyline is an experimental drug. We want to see their effects on levels of hormones in the blood and prostate. In addition, we will be examining the effects of these drugs on the expression of genes within the prostate.
Acyline suppresses LH and FSH, which are hormones made by the pituitary gland, thus blocking the signal from the brain that causes the testes to make testosterone. Therefore, Acyline blocks testosterone production. In preliminary studies, a single injection of Acyline reversibly lowered the FSH, LH and testosterone levels in the blood for approximately 15 days. Prolonged low levels of LH and FSH cause suppression of sperm production in normal men. However, men may experience some side effects from the low levels of testosterone caused by acyline, thus exogenous testosterone is required to sustain normal male androgen and organ effects without suppressing spermatogenesis. This combination of drugs is a promising male contraceptive regimen. In addition, millions of older men are using testosterone replacement to treat male "andropause"; low level testosterone associated with aging. However, the effect of testosterone on the prostate is unknown. Studies examining the effect of testosterone on the prostate are needed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Testosterone gel 100 mg daily for 4 weeks
Other names: Testim
Acyline 300 μg/kg every two weeks (2 doses) for 4 weeks
Placebo acyline injections every two weeks (2 doses)
placebo testosterone gel daily for 4 weeks
Time frame: 28-days
Time frame: 28-days
University of Washington
Other
The Effects of Testosterone on Prostate Tissue in Normal Men (ACYP-1)
Acronym: ACYP-1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00663793
Contraception, Endocrine System Diseases
Seattle, Washington, United States
View Trial DetailsNCT00161421
Contraception, Endocrine System Diseases
Seattle, Washington, United States
View Trial DetailsNCT01511588
Adolescents, Amenorrhea
Bethesda, Maryland, United States
View Trial DetailsNCT03887936
Diabetes Mellitus, Diabetes Mellitus, Type 2
Houston, Texas, United States
View Trial Details